BioMarin Pharma (BMRN) Announces Updated Strategy for ROCTAVIAN to Focus on U.S., Germany and Italy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to BioMarin Pharma (BMRN) Announces Updated Strategy for ROCTAVIAN to Focus on U.S., Germany and Italy

BioMarin Announces Updated Strategy for ROCTAVIAN® to Focus on U.S., Germany and Italy

August 5, 2024 4:01 PM EDT

Strategic Focus will Reduce Operating Expenses with the Goal of Achieving ROCTAVIAN Profitability by End of 2025

BioMarin to Provide Continued Monitoring and Support to Those Treated in Clinical Trials and Commercially

SAN RAFAEL, Calif., Aug. 5, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced it will make changes to its ROCTAVIAN® business to focus commercial operations on three... More